Does Medicare Part D cover oral cancer pills like Ibrance, Kisqali, or anastrozole, and how much will I pay out of pocket?

Answered by 6 licensed agents

Usually, yes—if you’re enrolled in a Medicare Part D plan, either stand-alone or through Medicare Advantage with drug coverage. Oral cancer medicines are commonly handled under Part D, but each plan has its own formulary and may require prior authorization or quantity limits. Check the exact drug and dose with your plan.

medicare.gov

Your 2026 cost depends on your plan, including its deductible, copay or coinsurance, and whether the medicine is preferred. Anastrozole is a generic and may have a lower copay; Ibrance and Kisqali may have higher cost-sharing. I can’t estimate an exact amount without your plan details.

The key protection: in 2026, your total out-of-pocket spending for covered Part D drugs is capped at $2,100 for the year—across all covered Part D medicines, not $2,100 per drug. After reaching the cap, you pay nothing for covered Part D drugs for the rest of that calendar year. The cap doesn’t make a non-covered drug covered.

medicare.gov

To get your actual price, check your plan’s 2026 formulary or call the plan and ask for the member cost for your specific dose and pharmacy. If you share your plan name and state, I can help you figure out what to look for.

Sources

Answered by John Hose on November 9, 2026

Broker Licensed in MD, FL, NC & 7 other states

Answered by John Hose Medicare Insurance Agent
Medicare Part D may cover oral cancer medications such as Ibrance, Kisqali, and anastrozole, depending on the plan's formulary and coverage requirements.

In 2026, out-of-pocket costs for covered Part D medications are capped at $2,100 annually. Actual costs depend on the plan and medication. A local Medicare agent can help compare plans and check drug coverage.

Answered by Mary Brown on November 9, 2026

Broker Licensed in NJ, DE, FL & 5 other states

Answered by Mary Brown Medicare Insurance Agent
Medicare Part D and Medicare Advantage plans with prescription drug coverage generally cover oral oncology medications like Ibrance, Kisqali, or anastrozole, though they are typically placed on specialty tiers requiring coinsurance or prior authorization. Thanks to the ongoing rollout of the Medicare prescription payment reforms and out-of-pocket spending caps, your maximum annual out-of-pocket costs for these vital prescriptions are strictly limited, and you also have the option to spread those costs out evenly across the year.

Answered by Michael Cambigue on November 12, 2026

Broker Licensed in CT & FL

Answered by Michael Cambigue Medicare Insurance Agent
Yes, Medicare Part D does cover these drugs, but because these are pills, and taken by you and not given by IV's, they are handled by your Part D plan. Your you have met your co-insurance and deductible's, your co-pay would be $0.

Answered by Lynn Platt on November 9, 2026

Broker Licensed in NY

Answered by Lynn Platt Medicare Insurance Agent
You can pull up the specific plan formulary to look up covered meds and copays. Most Part D plans offer online formulary lists or you can call your Part D carrier to get coverage and price information. You can also go to www.medicare.gov and manually key in those meds to get cost and formulaty information.

Answered by Cindy Dedini on November 16, 2026

Broker Licensed in CA, AZ, CO & 11 other states

Answered by Cindy Dedini Medicare Insurance Agent
Always get with an agent to run your scripts along with the plan benefits so you have an idea of what your out of pocket costs may be even though formularies can change for carriers.

Answered by Jennifer Wesolek on November 9, 2026

Agent Licensed in KY

Answered by Jennifer Wesolek Medicare Insurance Agent

Tags: Coverage Medicare Part D Prescription Drug

Agents: Share Your Expertise

Have insights or experiences related to this topic? Help others by sharing your knowledge and answering this question.

Seniors: Ask a Question of Your Own

Questions are generally answered within 1 to 3 business days. Receive valuable perspectives from multiple licensed agents and brokers.

Ask a Question